CME: Examining Medicare Prescribing of Painkillers

CME: Examining Medicare Prescribing of Painkillers
Author Information (click to view)

Anna Lembke, MD

Assistant Professor of Psychiatry and Behavioral Sciences
Chief, Addiction Medicine Dual Diagnosis Clinic
Program Director, Stanford Addiction Medicine Fellowship
Stanford University School of Medicine

Anna Lembke, MD, has indicated to Physician’s Weekly that she has or has had no financial interests to report.

+


Anna Lembke, MD (click to view)

Anna Lembke, MD

Assistant Professor of Psychiatry and Behavioral Sciences
Chief, Addiction Medicine Dual Diagnosis Clinic
Program Director, Stanford Addiction Medicine Fellowship
Stanford University School of Medicine

Anna Lembke, MD, has indicated to Physician’s Weekly that she has or has had no financial interests to report.

Recent data show that opioid prescribing for Medicare Part D patients is a widespread practice. Efforts to curtail opioid overprescribing must address a broad group of prescribers to be effective.
Share on FacebookTweet about this on TwitterShare on LinkedIn
Readings & Resources (click to view)

Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of opioids by different types of Medicare prescribers. JAMA Intern Med. 2015 Dec 14 [Epub ahead of print]. Available at: http://archinte.jamanetwork.com/article.aspx?articleid=2474400.

Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309:657-659.

Rosenau AM. Guidelines for opioid prescription: the devil is in the details. Ann Intern Med. 2013;158:843-844.

Betses M, Brennan T. Abusive prescribing of controlled substances: a pharmacy view. N Engl J Med. 2013;369:989-991.

ReedWJ. The Pareto, Zipf, and other power laws. Econ Lett. 2001;74:15-19.

Submit a Comment

Your email address will not be published. Required fields are marked *

3 × 5 =